The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think ...

Current scans often fail ... for additional consideration on how certain medications, especially GLP-1 agonists, can be used to treat obesity and diabetes in ... Oct. 10, 2024 — A new study ...

Francis Howell’s current fund balance was insufficient to meet growing ... Francis Howell’s health plan will continue to ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Can medications associated with comorbidities ... How should the presence of diabetic kidney disease affect current clinical management of diabetes? 16. Do novel kidney disease CVD pathways ...